Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains

FEBS Lett. 2000 Jul 28;478(1-2):183-6. doi: 10.1016/s0014-5793(00)01850-0.


The MDM2 oncoprotein is a negative regulatory partner of the p53 tumour suppressor. MDM2 mediates ubiquitination of p53 and targets the protein to the cytoplasm for 26S proteosome-dependent degradation. In this paper, we show that MDM2 is modified in cultured cells by multisite phosphorylation. Deletion analysis of MDM2 indicated that the sites of modification fall into two clusters which map respectively within the N-terminal region encompassing the p53 binding domain and nuclear export sequence, and the central acidic domain that mediates p14(ARF) binding, p53 ubiquitination and cytoplasmic shuttling. The data are consistent with potential regulation of MDM2 function by multisite phosphorylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Cell Line
  • Chymotrypsin / metabolism
  • Humans
  • Mice
  • Mutation
  • Nuclear Proteins*
  • Peptide Fragments / chemistry
  • Peptide Fragments / metabolism
  • Peptide Mapping
  • Phosphates / metabolism
  • Phosphopeptides / chemistry
  • Phosphopeptides / metabolism
  • Phosphorylation
  • Protein Structure, Tertiary
  • Proto-Oncogene Proteins / chemistry*
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogene Proteins c-mdm2
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Transfection
  • Tumor Suppressor Protein p53 / metabolism
  • Ubiquitins / metabolism


  • Nuclear Proteins
  • Peptide Fragments
  • Phosphates
  • Phosphopeptides
  • Proto-Oncogene Proteins
  • Recombinant Fusion Proteins
  • Tumor Suppressor Protein p53
  • Ubiquitins
  • MDM2 protein, human
  • Mdm2 protein, mouse
  • Proto-Oncogene Proteins c-mdm2
  • Chymotrypsin